Role of hemodynamics in pulmonary vascular remodeling: Implications for primary pulmonary hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 361-364

  Botney, Mitchell D ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL INJURY; CARDIOPULMONARY HEMODYNAMICS; ENDOTHELIUM INJURY; LUNG BLOOD VESSEL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SHEAR STRESS;

EID: 0033047617     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9805075     Document Type: Review

References (35)

1. Botney, M. D., L. R. Kaiser, J. D. Cooper, R. P. Mecham, J. Roby, and W. C. Parks. 1992. Extracellular matrix protein gene expression in atherosclerotic pulmonary arteries. Am. J. Pathol. 140:357-364.
2. Botney, M. D., M. J. Liptay, L. R. Kaiser, J. D. Cooper, W. C. Parks, and R. P. Mecham. 1993. Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am. J. Pathol. 143:121-129.
3. Liptay, M. J., W. C. Parks, R. P. Mecham, J. Roby, L. R. Kaiser, J. D. Cooper, and M. D. Botney. 1993. Neointimal macrophages co-localize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91:588-594.
4. Botney, M. D., L. Bahadori, and L. I. Gold. 1994. Vascular remodeling in primary pulmonary hypertension: potential role for transforming growth factor-β. Am. J. Pathol. 144:286-295.
5. Bahadori, L., J. Milder, L. I. Gold, and M. D. Botney. 1995. Active macrophage-associated TGF-β colocalizes with type I procollagen gene expression in atherosclerotic human hypertensive pulmonary arteries. Am. J. Pathol. 146:1140-1149.
6. Stenmark, K. R., and R. P. Mecham. 1997. Cellular and molecular mechanisms of pulmonary vascular remodeling. Ann. Rev. Physiol. 59:89-144.
7. Mette, S. A., H. I. Palevsky, G. G. Pietra, T. M. Williams, E. Bruder, A. J. Prestipino, A. M. Patrick, and J. A. Wirth. 1992. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am. Rev. Respir. Dis. 145:1196-1200.
8. Widgren, S. 1977. Pulmonary hypertension related to Aminorex intake. In E. Grundmann and W. H. Kirsten, editors. Current Topics in Pathology. Springer, New York. 1-64.
9. Barst, R. J., E. R. Flaster, A. Menon, M. Fotino, and J. H. Morse. 1992. Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 85:249-258.
10. Heath, D., E. H. Wood, J. W. DuShane, and J. E. Edwards. 1960. The relation of age and blood pressure to atheroma in the pulmonary arteries and thoracic aorta in congenital heart disease. Lab. Invest. 9:259-272.
11. Glagov, S., and A. K. Ozoa. 1968. Significance of the relatively low incidence of atherosclerosis in the pulmonary, renal, and mesenteric arteries. Ann. N. Y. Acad. Sci. 149:940-955.
12. Wissler, R. W., and D. Vesselinovitch. 1990. Atherogenesis in the pulmonary artery. In A. P. Fishman, editor. The Pulmonary Circulation: Normal and Abnormal. University Pennsylvania Press, Philadelphia, PA. 245-255.
13. Tanaka, Y., D. P. Schuster, E. C. Davis, G. A. Patterson, and M. D. Botney. 1996. The role of vascular injury and hemodynamics in pulmonary artery remodeling. J. Clin. Invest. 98:434-442.
14. Okada, K., Y. Tanaka, M. Bernstein, W. Zhang, G. A. Patterson, and M. D. Botney. 1997. Pulmonary hemodynamics modify the rat pulmonary artery response to injury: a neointimal model of pulmonary hypertension. Am. J. Pathol. 151:1019-1025.
15. Todorovich-Hunter, L., D. J. Johnson, P. Ranger, F. W. Keeley, and M. Rabinovilch. 1988. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline: a biochemical and ultrastructural study. Lab. Invest. 58:184-195.
16. Stenmark, K. R., M. L. Morganroth, L. K. Remigio, N. F. Voelkel, R. C. Murphy, P. M. Henson, M. M. Mathias, and J. T. Reeves. 1985. Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am. J. Physiol. 248:H859-H866.
17. Kameji, K., H. Otsuka, and Y. Hayashi. 1980. Increase of collagen synthesis in pulmonary arteries of monocrotaline-treated rats. Experientia 36:441-442.
18. Arcot, S. S., D. W. Lipke, M. N. Gillespie, and J. W. Olson. 1993. Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 46:1086-1091.
19. Tanaka, Y., M. L. Bernstein, R. P. Mecham, G. A. Patterson, J. D. Cooper, and M. D. Botney. 1996. Site-specific responses to monocrotaline-induced vascular injury: evidence for two distinct mechanisms of remodeling. Ant. J. Respir. Cell Mol. Biol. 15:390-397.
20. Kido, M., T. Hirose, K. Tanaka, T. Kurozumi, and Y. Shoyama. 1981. Increased alveolar-capillary membrane permeability by monocrotaline. Jap. J. Med. 20:170-179.
21. Liaw, L., and S. M. Schwartz. 1993. Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro: differences in growth regulatory molecules. Arterioscler. Thromb. 13:985-993.
22. Taguchi, J., C. E. Murry, B. I. Herren, M. Pech, S. M. Schwartz, and V. Lindner. 1998. A quantitative method for determination of endothelial mRNA expression in vivo. Am. J. Pathol. 152:903-912.
23. Okada, K., M. Bernstein, W. Zhang, D. P. Schuster, and M. D. Botney. 1998. Angiotensin converting enzyme inhibition delays pulmonary vascular neointimal formation. Am. J. Respir. Crit. Care Med. 158:939-950.
24. Davies, P. F. 1995. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:519-560.
25. Ingber, D. 1991. Integrins as mechanochemical transducers. Curr. Opin. Cell Biol. 3:841-848.
26. Kim, D. W., A. I. Gotlieb, and B. L. Langille. 1989. In vivo modulation of endothelial F-actin microfilaments by experimental alterations in shear stress. Arteriosclerosis 9:439-445.
27. Kohler, T. R., and A. Jawien. 1992. Flow affects development of intimal hyperplasia after arterial injury in rats. Arterioscler. Thromb. 12:963-971.
28. Berk, B. C., M. A. Corson, T. E. Peterson, and H. Tseng. 1995. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent, and calcium-independent events activated by flow. J. Biomech. 28:1439-1450.
29. Clowes, A. W., M. A. Reidy, and M. M. Clowes. 1983. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:327-336.
30. Powell, R. J., J. Hydowski, O. Frank, J. Bhargava, and B. E. Sumpio. 1997. Endothelial cell effect on smooth muscle cell collagen synthesis. J. Surg. Res. 69:113-118.
31. Dubey, R. K., E. K. Jackson, and T. F. Luscher. 1995. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin-receptors. J. Clin. Invest. 96:141-149.
32. Garg, U. C., and A. Hassid. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
33. Castellot, J. J., M. L. Addonizio, R. Rosenberg, and M. J. Karnovsky. 1981. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J. Cell Biol. 90:372-379.
34. van Hinsbergh, W. M. 1997. Endothelial permeability for macromolecules: mechanistic aspects of pathophysiological modulation. Arterioscler. Thromb. Vasc. Biol. 17:1018-1023.
35. Waters, C. M. 1996. Flow-induced modulation of the permeability of endothelial cells cultured on microcarrier beads. J. Cell. Physiol. 168:403-411.